General Information of Drug Transporter (DT)
DT ID DTD0474 Transporter Info
Gene Name SLC7A7
Transporter Name Y+L amino acid transporter 1
Gene ID
9056
UniProt ID
Q9UM01
Epigenetic Regulations of This DT (EGR)

Methylation

  Bladder cancer

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC7A7 in bladder cancer [ 1 ]

Location

TSS1500 (cg19599045)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.35E+00 Statistic Test p-value: 3.32E-07; Z-score: -7.20E+00

Methylation in Case

5.44E-01 (Median) Methylation in Control 7.33E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC7A7 in bladder cancer [ 1 ]

Location

TSS1500 (cg24970620)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.14E+00 Statistic Test p-value: 8.95E-07; Z-score: -6.55E+00

Methylation in Case

7.42E-01 (Median) Methylation in Control 8.48E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC7A7 in bladder cancer [ 1 ]

Location

TSS200 (cg16465430)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.31E+00 Statistic Test p-value: 3.25E-02; Z-score: -2.22E+00

Methylation in Case

1.77E-01 (Median) Methylation in Control 2.32E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Breast cancer

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC7A7 in breast cancer [ 2 ]

Location

TSS1500 (cg19599045)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.20E+00 Statistic Test p-value: 5.10E-12; Z-score: -3.08E+00

Methylation in Case

6.34E-01 (Median) Methylation in Control 7.64E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC7A7 in breast cancer [ 2 ]

Location

TSS1500 (cg24970620)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.26E+00 Statistic Test p-value: 1.48E-11; Z-score: -2.03E+00

Methylation in Case

5.81E-01 (Median) Methylation in Control 7.32E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC7A7 in breast cancer [ 2 ]

Location

TSS200 (cg16465430)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.13E+00 Statistic Test p-value: 2.55E-02; Z-score: -5.75E-01

Methylation in Case

3.14E-01 (Median) Methylation in Control 3.55E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Renal cell carcinoma

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC7A7 in clear cell renal cell carcinoma [ 3 ]

Location

TSS1500 (cg24970620)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 1.85E-03; Z-score: -4.62E-01

Methylation in Case

8.56E-01 (Median) Methylation in Control 8.72E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC7A7 in clear cell renal cell carcinoma [ 3 ]

Location

TSS200 (cg16465430)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.30E+00 Statistic Test p-value: 4.44E-03; Z-score: 1.28E+00

Methylation in Case

2.28E-01 (Median) Methylation in Control 1.76E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Colon cancer

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC7A7 in colon adenocarcinoma [ 4 ]

Location

TSS1500 (cg00390253)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.14E+00 Statistic Test p-value: 6.94E-04; Z-score: -1.52E+00

Methylation in Case

6.35E-01 (Median) Methylation in Control 7.21E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC7A7 in colon adenocarcinoma [ 4 ]

Location

Body (cg01922613)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.08E+00 Statistic Test p-value: 3.25E-04; Z-score: 7.69E-01

Methylation in Case

7.78E-01 (Median) Methylation in Control 7.20E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Colorectal cancer

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC7A7 in colorectal cancer [ 5 ]

Location

TSS1500 (cg18543242)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.14E+00 Statistic Test p-value: 1.91E-03; Z-score: -1.01E+00

Methylation in Case

6.07E-01 (Median) Methylation in Control 6.90E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC7A7 in colorectal cancer [ 5 ]

Location

TSS1500 (cg24970620)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.12E+00 Statistic Test p-value: 7.09E-03; Z-score: -8.25E-01

Methylation in Case

6.30E-01 (Median) Methylation in Control 7.07E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC7A7 in colorectal cancer [ 5 ]

Location

TSS1500 (cg19599045)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 1.30E-02; Z-score: -5.68E-01

Methylation in Case

8.40E-01 (Median) Methylation in Control 8.91E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC7A7 in colorectal cancer [ 5 ]

Location

TSS200 (cg16465430)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.18E+00 Statistic Test p-value: 1.72E-02; Z-score: -8.59E-01

Methylation in Case

4.72E-01 (Median) Methylation in Control 5.59E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Hepatocellular carcinoma

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC7A7 in hepatocellular carcinoma [ 6 ]

Location

TSS1500 (cg19599045)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.22E+00 Statistic Test p-value: 1.37E-05; Z-score: -1.07E+00

Methylation in Case

4.36E-01 (Median) Methylation in Control 5.33E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC7A7 in hepatocellular carcinoma [ 6 ]

Location

TSS1500 (cg18543242)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 3.58E-02; Z-score: -5.73E-01

Methylation in Case

5.00E-01 (Median) Methylation in Control 5.38E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC7A7 in papillary thyroid cancer [ 7 ]

Location

TSS1500 (cg18543242)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.08E+00 Statistic Test p-value: 1.95E-03; Z-score: 1.43E+00

Methylation in Case

7.85E-01 (Median) Methylation in Control 7.24E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC7A7 in papillary thyroid cancer [ 7 ]

Location

TSS1500 (cg24970620)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 3.12E-02; Z-score: -4.23E-01

Methylation in Case

8.78E-01 (Median) Methylation in Control 8.88E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Prostate cancer

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC7A7 in prostate cancer [ 8 ]

Location

1stExon (cg13672791)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.19E+00 Statistic Test p-value: 1.64E-02; Z-score: 1.84E+00

Methylation in Case

8.31E-01 (Median) Methylation in Control 6.98E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC7A7 in prostate cancer [ 8 ]

Location

Body (cg18677871)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.14E+00 Statistic Test p-value: 1.84E-02; Z-score: 2.31E+00

Methylation in Case

8.03E-01 (Median) Methylation in Control 7.04E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Pancretic ductal adenocarcinoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC7A7 in pancretic ductal adenocarcinoma [ 9 ]

Location

Body (cg23930334)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.36E+00 Statistic Test p-value: 9.23E-03; Z-score: -1.52E+00

Methylation in Case

1.62E-01 (Median) Methylation in Control 3.83E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Multilayered rosettes embryonal tumour

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypomethylation of SLC7A7 in multilayered rosettes embryonal tumour than that in healthy individual

Studied Phenotype

Multilayered rosettes embryonal tumour [ICD-11:2A00.1]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 2.94E-14; Fold-change: -0.249251781; Z-score: -2.255018263
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

microRNA

  Unclear Phenotype

         12 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

miR-196a directly targets SLC7A7 [ 10 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-196a miRNA Mature ID miR-196a-5p

miRNA Sequence

UAGGUAGUUUCAUGUUGUUGGG

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)

  Epigenetic Phenomenon 2

miR-3065 directly targets SLC7A7 [ 10 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-3065 miRNA Mature ID miR-3065-3p

miRNA Sequence

UCAGCACCAGGAUAUUGUUGGAG

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)

  Epigenetic Phenomenon 3

miR-338 directly targets SLC7A7 [ 10 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-338 miRNA Mature ID miR-338-3p

miRNA Sequence

UCCAGCAUCAGUGAUUUUGUUG

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)

  Epigenetic Phenomenon 4

miR-3689a directly targets SLC7A7 [ 10 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-3689a miRNA Mature ID miR-3689a-5p

miRNA Sequence

UGUGAUAUCAUGGUUCCUGGGA

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)

  Epigenetic Phenomenon 5

miR-3689b directly targets SLC7A7 [ 10 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-3689b miRNA Mature ID miR-3689b-5p

miRNA Sequence

UGUGAUAUCAUGGUUCCUGGGA

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)

  Epigenetic Phenomenon 6

miR-3689e directly targets SLC7A7 [ 10 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-3689e miRNA Mature ID miR-3689e

miRNA Sequence

UGUGAUAUCAUGGUUCCUGGGA

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)

  Epigenetic Phenomenon 7

miR-3689f directly targets SLC7A7 [ 10 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-3689f miRNA Mature ID miR-3689f

miRNA Sequence

UGUGAUAUCGUGCUUCCUGGGA

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)

  Epigenetic Phenomenon 8

miR-4530 directly targets SLC7A7 [ 10 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-4530 miRNA Mature ID miR-4530

miRNA Sequence

CCCAGCAGGACGGGAGCG

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)

  Epigenetic Phenomenon 9

miR-4679 directly targets SLC7A7 [ 10 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-4679 miRNA Mature ID miR-4679

miRNA Sequence

UCUGUGAUAGAGAUUCUUUGCU

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)

  Epigenetic Phenomenon 10

miR-5586 directly targets SLC7A7 [ 10 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-5586 miRNA Mature ID miR-5586-5p

miRNA Sequence

UAUCCAGCUUGUUACUAUAUGC

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)

  Epigenetic Phenomenon 11

miR-5701 directly targets SLC7A7 [ 10 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-5701 miRNA Mature ID miR-5701

miRNA Sequence

UUAUUGUCACGUUCUGAUU

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)

  Epigenetic Phenomenon 12

miR-6804 directly targets SLC7A7 [ 10 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-6804 miRNA Mature ID miR-6804-3p

miRNA Sequence

CGCACCUGCCUCUCACCCACAG

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)
References
1 DNA Methylation Dynamics in Urological Tumors.
2 Genome-wide Scan for Methylation Profiles in Breast Cancer
3 A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
4 Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013 Sep;8(9):921-34.
5 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
6 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
7 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
8 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
9 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
10 Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. Genes Dev. 2011 Oct 15;25(20):2173-86.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.